Epistaxis Market: An Insight On the Important Factors and Trends Influencing the Market

Epistaxis is a condition that results in uncertain nose bleeding from either of the nostrils. This clinical condition is usually classified as anterior epistaxis and posterior epistaxis based on the site where the bleeding originates. Epistaxis is rarely life threatening unless it is associated with chronic disorders such as cancer. About 10% of nosebleeds is life threatening, and it is accounted that four of the 2.4 million deaths occur due to epistaxis. This condition commonly occurs in younger children (2-10 years) and older people (50-80 years); however, it is more common among individuals who are above 50 years of age.

Prevalence is higher in males (58%) as compared to females (42%). It is usually caused by local trauma, including nasal infection and even nose picking. Environmental factors causing epistaxis include dry climate, lack of humidity in the atmosphere, or prolong inhalation of dry air. People who are on medications such as warfarin, clopidogrel, aspirin, or any other anticoagulant medications are more susceptible to epistaxis.

Other predisposing factors such as infection, allergic and non-allergic rhinitis, cocaine snorting, hypertension, alcohol abuse, and inherited bleeding problems also lead to epistaxis. In terms of treatment, the global epistaxis market is segmented as topical vasoconstrictors, antibiotic ointments (mupirocin), anesthetics, and nasal cautery.

Obtain Report Details @

https://www.transparencymarketresearch.com/epistaxis-market.html

The topical vasoconstrictors segment includes oxymetazoline, co-phenylcaine, or adrenaline, which are applied directly to the mucous membrane. The anesthetics segment includes lidocaine or lignocaine and is often given in combination with vasoconstrictors. Nasal cautery is the most common treatment of epistaxis. Chemical cautery (silver nitrate) and electrocautery (an electrically charged wire such as platinum) are two types of nasal cautery. Chemical cautery is the most popular method for the treatment of idiopathic recurrent epistaxis.

Most of the research is focused on device development, thus boosting the growth of the epistaxis market. In 2016, Smith & Nephew launched a range of epistaxis management devices using ‘rapid rhino technology’ that has a blend of carboxymethyl cellulose (CMC), which exhibit self-lubricating properties that provide gentle and even compression to the nasal area and helps in the quicker re-conformation of the nasal anatomy.

Request Sample @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35927

Additionally, growing incidence rates of epistaxis and chronic diseases boost the growth of the global epistaxis market. The lifelong incidence rate of epistaxis among the general population is about 60%, of which only 10% seeks medical treatment. This factor is projected to restrain the growth of the market during the forecast period.

In terms of geography, the global epistaxis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest share of the global epistaxis market, followed by Europe, due to higher incidence and prevalence rate of the condition and increase in research and development expenditure. Asia Pacific is an emerging market for epistaxis due to the developing health care infrastructure, increase in patient pool, and rising government expenditure in the health care industry.

However, in regions such as Middle East & Africa and Latin America, poor patient awareness and lack of availability of different treatment options are factors restraining the market growth. Key players operating in the global epistaxis market include Smith & Nephew, CIRON Drugs & Pharmaceuticals Pvt. Ltd., Bristol-Myers Squibb, Medline Industries, Inc., and King Pharmaceuticals, Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.